Highest priority programs – BEAM-101 and ESCAPE for sickle cell disease and BEAM-302 for alpha-1 antitrypsin deficiency – expected to provide foundation for meaningful value creation Company to ...

Cash, cash equivalents, and short-term investments of $113.1 million as of December 31, 2024, extend operational runway into the first quarter of 2026. Completion of enrollment in the ENERGY 3 pivotal ...

Tsukuba, Japan—The human genome contains approximately 1,600 types of transcription factors responsible for regulating gene activity across more than 400 tissue and cell types. Chromatin ...

Caribou Biosciences, Inc. announced a strategic shift focusing on its lead oncology programs, CB-010 and CB-011, involving workforce and cost reductions aimed at extending its cash runway into the ...

– Strategic restructuring includes reduced operating expenses, delivering approximately $400 million in anticipated annual cost savings, and implementing a 36% workforce reduction of approximately 500 ...

Realigning resources to focus on clinical advancement of Selected TIL therapy Reducing employee headcount by approximately 60% Streamlining operations with cash runway expected to extend into 2Q 2026 ...

CEO Erik Holmlin highlighted a strategic shift toward optimizing the utilization of existing optical genome mapping (OGM) systems among core customers. The company aims to focus its efforts on its 118 ...

In the modern and accelerated world of high-stakes corporate projects, it’s easy to feel overwhelmed by constant demands and pressures. Everything seems urgent, every task appears to be priority one ...

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--iQor, a leading managed services provider of digitally enabled business process outsourcing solutions, today announced a rigorous IT prioritization process ...